Genmab A/SGMABNASDAQ
Loading
Net Margin Over TimeContracting
Percentile Rank21
3Y CAGR-18.4%
5Y CAGR-15.4%
Studio
Year-over-Year Change

Net income as a percentage of revenue

3Y CAGR
-18.4%/yr
vs -6.3%/yr prior
5Y CAGR
-15.4%/yr
Recent deceleration
Acceleration
-12.2pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM20.40%-44.0%
202436.44%+37.9%
202326.42%-29.7%
202237.59%+7.0%
202135.13%-25.3%
202047.06%+16.6%
201940.37%-17.1%
201848.66%+4.3%
201746.65%-28.6%
201665.36%-